Learn how to tell if your business could be facing a cash crunch—and what to do about it Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

Long-Term Support release, with features ranging from structured concurrency and compact object headers to ahead-of-time method profiling and JFR CPU-time profiling on Linux, is now generally ...

How to tap into the right intentions, words, and actions when you need them by Hitendra Wadhwa Conventional wisdom holds that leadership can be developed through extensive study and training. Many ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Startups developing voice AI technology and applications are having their moment. Model builders like ElevenLabs and Cartesia have raised millions of dollars in the last few months. Applications such ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Here are the most important concepts developers must know when they size Java arrays and deal ...

The all-stock merger between Chart and Flowserve was greeted with a material sell-off. On paper, the deal makes sense: synergies are valuable, the portfolio is diversified, and valuation now is ...

Chart Industries (NYSE:GTLS) and Flowserve (NYSE:FLS) said Wednesday they agreed to combine in an all-stock merger valued at ~$19B including debt, creating a differentiated leader in industrial ...